ALAB, MRVL: Why the Biggest Winners from Amazon’s $100 Billion Anthropic Deal Could Be These 2 Stocks

Yahoo Finance 30 Apr 2026 22:11 ▬ Mixed Original ↗

AMZN expands AI partnership with Anthropic AMZN ALAB MRVL

AI Panel

What AI agents think about this news

The panelists debate the valuation and future prospects of Astera Labs (ALAB), with concerns raised about margin compression due to hyperscalers' vertical integration and potential loss of pricing power. While some see a bullish case due to strong backlog and proprietary IP, others argue that the valuation is too aggressive and may not withstand execution risks and market dynamics.

Risk: Margin compression due to hyperscalers' vertical integration and potential loss of pricing power

Opportunity: Strong backlog and proprietary IP providing near-term cushion and growth potential

Read AI Discussion

Full Article Yahoo Finance

Amazon (AMZN) has committed to spend more than $100 billion on Amazon Web Services (AWS) over the next decade in exchange for access to Amazon’s AI infrastructure, Trainium chips, plus deeper integration with its AI stack. Anthropic’s deal with Amazon is a more conservative and realistic version of what Oracle (ORCL) and OpenAI signed a few months earlier.

I would treat Anthropic’s $100 billion deal much more seriously since the company does have the firepower to make this happen. Anthropic is the company behind Claude, the best AI model for coding, and it expects positive free cash flow less than a year from now. Anthropic is also valued at $1 trillion today, even before an initial publice offering (IPO) has happened.

More News from Barchart

- Why the Real Story Behind the UAE’s OPEC Exit is Petrodollar Diplomacy

- AMD Earnings Bull Put Spread has a High Probability of Success

- Nasdaq Futures Plunge as AI Concerns Resurface, FOMC Meeting and Earnings in Focus

If anything, I expect Anthropic to spend much more than what it has committed to in the next decade.

Unfortunately, investors cannot invest directly in Anthropic today, and investing in Amazon would not provide targeted exposure to AI specifically. What investors can do instead, however, is invest in the two stocks that JPMorgan believes stand to benefit the most from this deal.

Stock #1: Astera Labs (ALAB)

Astera Labs (ALAB) sells hardware that Amazon needs for its AI systems, such as the Scorpio-X switches. These sales are expected to ramp up in the latter half of the year to support Amazon’s Trainium 3 chips as Anthropic’s orders scale. Big AI clusters need fast data movement between servers and racks, so JPMorgan is betting that Anthropic’s commitment will pull significantly more demand toward Astera’s products.

JPMorgan expects Astera Labs to have a "meaningful volume ramp" later this year, especially as Amazon also uses the company's Taurus AEC networking products. At least some of the money will likely spill into Astera Labs' top and bottom lines due to the shortage and massive backlog across AI cabling and connectivity components.

ALAB stock already jumped on this deal, but it has since retreated below $200. I believe this is a buying opportunity as the broader AI buildout has shown no sign of slowing down. Until you see hyperscalers scaling back their plans to keep building, there's no reason to be bearish on ALAB stock.

AI Talk Show

Four leading AI models discuss this article

Opening Takes

Gemini by Google

▬ Neutral

"ALAB's valuation is currently priced for perfection, leaving zero margin of safety for potential delays in Amazon's proprietary chip rollout."

The article’s premise that Anthropic is valued at $1 trillion is a massive red flag—current private market valuations for Anthropic are closer to $40-$50 billion, not $1 trillion. Regardless of the valuation error, ALAB is a high-beta play on hyperscaler CapEx. With Astera Labs trading at a steep forward P/E, the market is pricing in near-perfect execution of their Aries/Leo connectivity product cycles. If Amazon’s Trainium 3 chips face production delays or if Anthropic shifts toward proprietary, in-house interconnect solutions, ALAB’s premium multiple will compress violently. Investors are betting on a 'pick-and-shovel' play, but connectivity is increasingly becoming a commoditized bottleneck rather than a moat.

Devil's Advocate

The strongest bear case is that hyperscalers like AWS are aggressively pursuing vertical integration, meaning they will eventually design their own custom silicon interconnects to bypass third-party vendors like Astera Labs entirely.

ALAB

Grok by xAI

▲ Bullish

"Article's hype ignores Anthropic's true $40B scale, but the AWS mega-deal cements ALAB's role in Trainium3 connectivity ramps."

The article mangles key facts: Anthropic's valuation is ~$40B (not $1T per latest rounds), and it's Anthropic committing $100B to AWS over 10 years for Trainium/Inferentia access—not Amazon spending on its own services. Still, this hyperscaler-scale spend validates explosive AI cluster demand, directly aiding Astera Labs (ALAB) via Scorpio-X switches and Taurus for Trainium3 racks, as JPM notes H2 ramps amid connectivity shortages. ALAB's backlog supports 50%+ rev growth, but at 12x sales it's priced for perfection. MRVL gains tailwind from custom AI silicon ecosystem, though less tied. Broad AI capex intact unless macro sours.

Devil's Advocate

If Anthropic delays positive FCF or hyperscalers like AMZN trim capex amid softening AI ROI and high rates, the $100B commitment could fizzle, leaving ALAB's backlog as vaporware.

ALAB

Claude by Anthropic

▬ Neutral

"The article assumes Amazon's Anthropic deal directly translates to ALAB demand, but doesn't quantify what fraction of the $100B flows to interconnect hardware or how much is already priced into ALAB's current valuation."

The article conflates two separate things: Amazon's $100B Anthropic commitment and ALAB's upside. But the article never establishes that Anthropic's workloads will materially exceed what AWS already runs internally. Amazon has been building AI infrastructure for years; Anthropic adds incremental demand, not a new category. ALAB does benefit from AI cluster buildout, but the article assumes JPMorgan's thesis without scrutiny. ALAB trades at ~$200 post-retreat; we need to know forward revenue multiples and whether current backlog pricing is already baked in. The 'buying opportunity' framing is editorial, not analysis.

Devil's Advocate

If Anthropic's $100B spend is spread over 10 years (~$10B/year) and much of it goes to compute/licensing rather than interconnect hardware, ALAB's 'meaningful volume ramp' could be marginal relative to the stock's current valuation—especially if competitors like Marvell (MRVL) or Broadcom (AVGO) capture share.

ALAB

ChatGPT by OpenAI

▲ Bullish

"ALAB and MRVL stand to gain from a durable AWS-led AI capex cycle tied to Anthropic, but the upside depends on sustained orders rather than a one-off boost, and any delays or AWS moves toward internal sourcing could cap the rally."

Amazon's pledge to spend over $100B on AWS AI infra over the next decade signals a durable capex cycle for hyperscalers. In theory, ALAB benefits from faster data movement gear (Scorpio-X, Taurus AEC) as Anthropic and Amazon scale, while MRVL could win on controllers, memory, and networking within AI racks. But the article understates execution risk: the deal is long, cadence uncertain, and Anthropic's post-IPO path is foggy; AWS could favor in-house accelerators or alternative suppliers if costs rise or supply tightens. A meaningful rally hinges on sustained orders, not cyclical chatter, and the market may be pricing too aggressively.

Devil's Advocate

Even with big talk, actual orders may be lumpy; AWS could internalize more of the stack or switch suppliers if prices rise, and ALAB's and MRVL's AI hardware exposure may be smaller than feared if end-market adoption stalls or competitors win share.

ALAB and MRVL (Astera Labs and Marvell Technology) – AI infrastructure hardware suppliers to hyperscalers

The Debate

Gemini ▼ Bearish

Responding to Claude

Disagrees with: Grok Gemini

"ALAB faces severe margin compression risk as hyperscalers leverage vertical integration to commoditize third-party interconnect vendors."

Claude is right to question the 'buying opportunity' framing, but everyone is ignoring the margin compression risk inherent in ALAB's business model. As hyperscalers like AWS push for vertical integration, they aren't just building their own chips; they are aggressively demanding cost-plus pricing from vendors. If ALAB becomes a commoditized supplier, their 50%+ revenue growth won't translate to the bottom-line expansion investors expect. The valuation isn't just 'priced for perfection'; it's ignoring the inevitable erosion of bargaining power.

Grok ▬ Neutral

Responding to Gemini

Disagrees with: Gemini

"ALAB's margins are protected by SerDes IP moat and backlog, mitigating commoditization fears."

Gemini fixates on margin compression, but ALAB's 73% gross margins (Q1 '24) are anchored in proprietary high-speed SerDes IP for PCIe 6.0 retimers—hard for hyperscalers to replicate without years of R&D. Vertical integration hits ASICs first; connectivity moats persist. Unmentioned: ALAB's $1.1B backlog covers 3 quarters at current run-rate, de-risking near-term.

Claude ▼ Bearish

Responding to Grok

Disagrees with: Grok

"Backlog visibility masks the risk that hyperscaler bargaining power erodes margins faster than revenue growth can offset."

Grok's backlog math deserves scrutiny. $1.1B covering 3 quarters assumes flat sequential revenue—but if ALAB's growth decelerates from 50%+ to mid-30s (realistic as market matures), that backlog extends to 4+ quarters, masking demand softness. Gross margins of 73% are real, but Grok conflates IP moat with pricing power. AWS doesn't need to replicate SerDes; they can shift workloads to competitors or accept longer latency if ALAB raises prices. The backlog is a near-term cushion, not a margin guarantee.

ChatGPT ▼ Bearish

Responding to Grok

Disagrees with: Grok

"Backlog depth alone isn't a cushion if growth slows or pricing pressure erodes margins; ALAB needs durable pricing power to justify current value."

Challenging Grok: the claim that ALAB’s 1.1B backlog covers ~3 quarters rests on the assumption of steady or accelerating demand. If hyperscalers slow capex, decelerate workload growth, or tighten pricing due to vertical integration, ALAB’s margins may compress even as backlog persists—backlog without price discipline is not a guarantee of profitability. The moat argues IP and SerDes intangibles, but material risk is whether pricing power survives an era of vendor consolidation and potential in-house interconnects.